Lataa...
A New “Brew” of MALT1 Inhibitors
The activated B cell-like (ABC) subtype of diffuse large B cell lymphoma (DLBCL) is an aggressive lymphoma that is addicted to NF-κB signaling through the CARD11-BCL10-MALT1 complex. In this issue of Cancer Cell, two reports describe MALT1 inhibitors suitable for clinical use that are selectively to...
Tallennettuna:
Päätekijät: | , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
2012
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4053348/ https://ncbi.nlm.nih.gov/pubmed/23238011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2012.11.011 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|